CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net loss	$ (8,782,606)	$ (7,936,864)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	887,930	550,682
Share-based payments for services	218,318	248,660
Equity based compensation	3,262,296	3,296,309
Common stock contributed to 401(k) plan	52,555	41,671
Gain on short-term investments	(615)
Loss on patent impairment	30,793
Gain on derivative instruments	(364,596)	(932,836)
Modification of warrants		192
(Increase)/decrease in assets:
Receivables		532,328
Prepaid expenses	144,542	(332,785)
Supplies used for R&D and manufacturing	(61,139)
Increase/(decrease) in liabilities:
Accounts payable	(523,152)	532,679
Accrued expenses	95,685	143,028
Due to employees	209,046	10,718
Other liabilities	24,997	18,319
Net cash used in operating activities	(4,805,946)	(3,827,899)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturity of US treasury bills	6,152,000
Purchases of property and equipment	(17,036)	(3,149,820)
Expenditures for patent costs	(22,741)
Net cash provided by (used in) investing activities	6,112,223	(3,149,820)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock		13,559,500
Payments of stock issuance costs	(32,800)	(79,499)
Proceeds from exercises of warrants and options	117,200	70,911
Payments on obligations under finance lease	(340,908)	(221,620)
Net cash (used in) provided by financing activities	(256,508)	13,329,292
NET INCREASE IN CASH AND CASH EQUIVALENTS	1,049,769	6,351,573
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	36,060,148	15,508,909
CASH AND CASH EQUIVALENTS, END OF PERIOD	37,109,917	21,860,482
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment included in current liabilities	469,005	1,700,969
Capitalizable patent costs included in current liabilities		15,000
Finance lease obligation included in accounts payable	771	1,752
Prepaid consulting services paid with issuance of common stock	233,753	243,687
Exercise of derivative liabilities	70,589	41,850
Financing costs included in current liabilities	13,165	88,021
Cash paid for interest	$ 290,212	$ 277,618